* Prosetta biosciences, inc. And takeda pharmaceutical
company limited, enter into agreement to discover and develop
novel compounds for neurodegenerative diseases
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +1-646-223-8780)
Read more
No comments:
Post a Comment